Treatment and outcome of myasthenia gravis: retrospective multi-center analysis of 470 Japanese patients, 1999-2000.
Kawaguchi
Naoki
N
Department of Neurology, Chiba University, 1-8-1 Inohna, Chuo, 260-8670, Japan. kawaguchi@faculty.chiba-u.jp
Kuwabara
Satoshi
S
Nemoto
Yuko
Y
Fukutake
Toshio
T
Satomura
Yoichi
Y
Arimura
Kimiyoshi
K
Osame
Mitsuhiro
M
Hattori
Takamichi
T
D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D015331:Cohort Studies; D004185:Disability Evaluation; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007223:Infant; D007564:Japan / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D009157:Myasthenia Gravis / Q000453:epidemiology / Q000628:therapy*; D010956:Plasmapheresis / Q000379:methods; D011950:Receptors, Cholinergic / Q000276:immunology; D012189:Retrospective Studies; D017678:Sex Distribution; D013934:Thymectomy / Q000379:methods; D016896:Treatment Outcome
D002800:Cholinesterase Inhibitors; D007166:Immunosuppressive Agents; D011950:Receptors, Cholinergic